Australia markets closed

Cytosorbents Corporation (CTSO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.8790+0.0690 (+8.52%)
As of 04:00PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 47.95M
Enterprise value 52.13M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.27
Price/book (mrq)2.06
Enterprise value/revenue 1.68
Enterprise value/EBITDA -1.79

Trading information

Stock price history

Beta (5Y monthly) 0.59
52-week change 3-64.27%
S&P500 52-week change 325.01%
52-week high 34.2900
52-week low 30.7820
50-day moving average 30.9409
200-day moving average 31.6742

Share statistics

Avg vol (3-month) 3103.21k
Avg vol (10-day) 381.66k
Shares outstanding 554.31M
Implied shares outstanding 654.29M
Float 846.68M
% held by insiders 19.38%
% held by institutions 138.04%
Shares short (28 Mar 2024) 41.62M
Short ratio (28 Mar 2024) 415.95
Short % of float (28 Mar 2024) 43.05%
Short % of shares outstanding (28 Mar 2024) 42.98%
Shares short (prior month 29 Feb 2024) 41.72M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:25
Last split date 305 Dec 2014

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -78.43%
Operating margin (ttm)-102.45%

Management effectiveness

Return on assets (ttm)-32.48%
Return on equity (ttm)-97.21%

Income statement

Revenue (ttm)36.35M
Revenue per share (ttm)0.81
Quarterly revenue growth (yoy)-7.70%
Gross profit (ttm)N/A
EBITDA -28.81M
Net income avi to common (ttm)-28.51M
Diluted EPS (ttm)-0.6400
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)14.13M
Total cash per share (mrq)0.26
Total debt (mrq)18.31M
Total debt/equity (mrq)78.68%
Current ratio (mrq)1.77
Book value per share (mrq)0.43

Cash flow statement

Operating cash flow (ttm)-21.66M
Levered free cash flow (ttm)-12.12M